A total of 60 fully vaccinated cancer patients received the third dose of COVID-19 vaccine at the National Cancer Institute (IKN) here today. National Cancer Institute (IKN) Medical deputy director 1 Dr Puteri Norliza Megat Ramli said the 60 were patients being treated at the IKN and were chosen for the third dose because they had low immunity. "Administering the third dose will prevent them from being infected with COVID-19 or from severe complications if infected. We will identify other cancer patients who will be given the third dose,” she told Bernama after observing...